Our focus is to help provide the evidence you need to support product value and access safe, effective treatments. PPD has created a dedicated unit combining our medical affairs research operations (MARO) and Evidera, a leading provider of evidence-based solutions, to demonstrate the real-world effectiveness, safety and value of biopharmaceutical and biotechnology products.
Our clinical experience in product development ensures collaboration and integration from pre-approval to post-approval. We provide a custom-tailored process, fine-tuned across the globe, to meet local regulatory requirements. Our operational model is based on a robust technology platform to support remote centralized management of our clients’ sites, and our operating procedures are designed for the post-approval setting.
We help our clients protect their investment with early post-approval planning.
Our teams provide high-quality, customizable programs that communicate essential product information to our customers quickly and cost-effectively.
PPD offers a comprehensive suite of post-approval medical writing services.
Our project managers provide quality deliverables on time and on budget, resulting in effective post-approval programs, including Phase IV trials.
PPD’s Research Coordination Center is a global center of expertise that focuses on remote site activities in support of late stage studies.
We deliver essential knowledge about drug use and treatment outcomes in real-world clinical practice through patient registries and observational studies.
PPD's real-world outcomes research delivers an important component of product development and commercialization services.
Our global pharmacovigilance team is comprised of physicians, pharmacists and other medically trained professionals.
PPD has a full range of capabilities and extensive experience supporting risk management and REMS programs for clients.
Review a list of PPD’s current pregnancy and lactation studies.